Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 3, 2023.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Live-Attenuated, Intranasal Vaccines Candidates for RSV and COVID-19
Could live attenuated vaccines and intranasal vaccines be the answer for RSV, COVID-19, and even cancer tumors?
Rodent Infestations and the Spread of Infectious Diseases
Rodents are known to transmit more than 35 illnesses. What signs should environmental services personnel and infection preventionists look for?
Norovirus: Preventing Spread in Food Service and Health Care Facilities
How can food service and health care workers prevent the spread of norovirus? Keeping employees at home, using the correct products the right way, and more.
Norovirus: What Experts Say About the 2022-2023 Season
Are norovirus cases going to skyrocket, or will the pandemic slowdown of this infectious disease continue?
FDA VRBPAC Meeting: Bivalent Vaccines, Natural Immunity, Imprinting, and COVID-19 Hospitalization Rates
The FDA's Vaccines and Related Biological Products Advisory Committee laid out a simpler direction for SARS-CoV-2 development and deployment.
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
“A Marathon and a Sprint”: Passing Surgical Smoke Legislation
March 9th 2024At the AORN’s International Surgical Conference & Expo 2024, a presentation on surgical smoke drew applause and strong emotion about the continuing fight for legislation on removing surgical smoke from operating rooms. Infection Control Today was there to tell you what happened.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.